2-chloro-1-4-[(3-fluorophenyl)methyl]piperazinylethan-1-one
95%
- Product Code: 157330
CAS:
1174869-30-7
| Molecular Weight: | 270.73 g./mol | Molecular Formula: | C₁₃H₁₆ClFN₂O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
Used primarily in pharmaceutical research as an intermediate in the synthesis of biologically active compounds. Its structure supports development of central nervous system agents, particularly those targeting neurotransmitter receptors. Commonly employed in the creation of selective receptor modulators due to its ability to cross blood-brain barrier and exhibit metabolic stability. Also utilized in medicinal chemistry for structure-activity relationship studies, helping optimize drug candidates for improved efficacy and safety.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1g | 10-20 days | $1,316.93 |
+
-
|
2-chloro-1-4-[(3-fluorophenyl)methyl]piperazinylethan-1-one
Used primarily in pharmaceutical research as an intermediate in the synthesis of biologically active compounds. Its structure supports development of central nervous system agents, particularly those targeting neurotransmitter receptors. Commonly employed in the creation of selective receptor modulators due to its ability to cross blood-brain barrier and exhibit metabolic stability. Also utilized in medicinal chemistry for structure-activity relationship studies, helping optimize drug candidates for improved efficacy and safety.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :